Technology | February 19, 2013

Think Tank Medical Releases App for Cardiologists to Determine Patient Eligibility for Implantable Devices

Application guides doctor through a series of questions on patient medical history to evaluate eligibility for an ICD, CRT-D and CRT-P

February 19, 2013 — In response to the astounding percentage of inappropriate and non-compliant ICD, CRT-P and CRT-D device implantations each year, Think Tank Medical has developed and released its CMS ICD Application, available for the iPhone and iPad to ensure that 100 percent of patients screened meet the evidence-based criteria for implantation.

The ICD (implantable cardioverter defibrillator) guidelines published by CMS (Center for Medicare and Medicaid Services) and utilized by cardiologists, electrophysiologist, and doctors nationwide to determine a patient’s eligibility for these cardiac devices are difficult to follow, even for the most experienced physician. Therefore, it is no surprise that the National Cardiovascular Registry has determined that 22.5 percent of all ICD implantations in the United States do not comply with Medicare guidelines. Furthermore, approximately 50 percent of patients who would otherwise be qualified for an ICD do not get such a device implanted.

In an effort to improve diagnosis of cardiac patients, the CMS ICD Application serves as a tool to guide a doctor through a series of “Yes” or “No” questions on patient medical history to evaluate a patient’s eligibility or ineligibility for an ICD, CRT-D and CRT-P in a matter of minutes. With the option to place automatic reminders in the iPhone or iPad calendar, re-evaluate patients who fall into mandatory waiting periods, to send emails to the doctor and office manager to schedule follow-up appointments or send test results to the doctor and compliance officer, the process is fully automated, standardized and error-free.

Andrew Paul, founder of Think Tank Medical states, “Our primary goal with the release of this free, medical application is to get it in the hands of as many doctors as possible. Our immediate objective is to help save lives, prevent non-compliant procedures and ensure patients who need an ICD, CRT-D or CRT-P get one. We hope to aid in the transformation and progressions of today’s seemingly complex healthcare industry and revolutionize the way eligibility determinations are made, in an error free manner and change the way the industry operates on a daily basis.”

He continues: “Sudden cardiac arrest kills 250,000 people each year in the United States. The chance of surviving an SCA event is about 5 percent. We want to change that.”

The complete list of features and benefits of the CMS ICD Application can be found at www.cmsicd.com.

The CMS ICD App can be downloaded directly from iTunes by searching "CMS ICD" in iTunes.

For more information: www.thinktankmedical.com

Related Content

Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
Technavio Projects 9 Percent Global Growth for Electrophysiology Therapeutic Devices

Image courtesy of Technavio

News | EP Lab| September 11, 2017
September 11, 2017 — According to the latest market study released by Technavio, the global...
Text Messaging Could Help Tackle High Blood Pressure in At-Risk Patients

Image courtesy of Michigan Medicine

News | Hypertension| September 06, 2017
A new National Institutes of Health-funded hypertension trial will examine the possibility of using an emergency...
EMANATE Trial Shows Apixaban Lowers stroke in AF Patients Undergoing Cardioversion.
News | Atrial Fibrillation| September 01, 2017
September 1, 2017 — Apixaban lowers the risk of stroke compared to warfarin in anticoagulation-naïve patients with at
CASTLE-AF Study shows Catheter Ablation of Atrial Fibrillation is First-Line Treatment for Heart Failure Patients. Biotronic Ilivia 7 ICD.

The CASTLE-AF Study shows catheter alation of AF can be used effectively to treat heart failure in patients with an implanted ICD.

News | Atrial Fibrillation| September 01, 2017
September 1, 2017 — Final results from the CASTLE-AF study show a 38 percent reduction in the composite of all-cause
Abbott. St. Jude Medical has updated its firmware to address cybersecurity issues with its Allure Quadra MP and other EP devices

Abbott. St. Jude Medical has updated its firmware to address cybersecurity issues with its Allure Quadra MP and other EP devices.

Feature | EP Lab| August 29, 2017 | Dave Fornell
August 29, 2017 — The U.S.
Biotronik Announces U.S. Launch of Edora HF-T QP CRT Pacemaker
Technology | Cardiac Resynchronization Therapy Devices (CRT)| August 21, 2017
Biotronik announced U.S. Food and Drug Administration (FDA) approval and commercial availability of Edora HF-T QP, an...
The FDA is concerned about cybersecurity of ICDs and cyber security of other medical devices.
Feature | Cybersecurity| August 16, 2017 | Dave Fornell
There is growing concern among patients and regulators that medical devices, especially implantable electrophysiology
Clarius Wireless Ultrasound Scanners Now Available With Advanced Features
News | Ultrasound Imaging| August 09, 2017
Clarius Mobile Health has released advanced features and options for its wireless handheld ultrasound scanner for...
Overlay Init